Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | TTR | P02766 | 1/20 | 0.48 |
| ▸ | ALB | P02768 | 1/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | GRM4 | Q14833 | 18/20 | 0.39 |
| ▸ | GRM8 | O00222 | 17/20 | 0.39 |
| ▸ | GRM6 | O15303 | 8/20 | 0.39 |
| ▸ | GRM7 | Q14831 | 4/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aclonifen SCHEMBL7576804 | 0.85 | MEN1 (0.66) | MEN1TTRALBTHRBKMT2A | |
| Aclonifen SCHEMBL7583158 | 0.81 | TDP1 (0.50) | MEN1TTRALBTHRBKMT2A | |
| Aclonifen SCHEMBL7582226 | 0.81 | MEN1 (0.47) | MEN1TTRALBTHRBKMT2A | |
| Bifenox SCHEMBL7582699 | 0.80 | TDP1 (0.55) | MEN1TTRKMT2ATDP1GRM4 | |
| Acifluorfen SCHEMBL7590402 | 0.79 | TDP1 (0.56) | MEN1TTRKMT2ATDP1GRM4 | |
| Oxyfluorfen SCHEMBL7580172 | 0.78 | MEN1 (0.44) | MEN1TTRKMT2ATDP1GRM4 | |
| Aclonifen SCHEMBL7587215 | 0.78 | TDP1 (0.49) | MEN1TTRALBTHRBKMT2A | |
| Glufosinate SCHEMBL7754316 | 0.77 | GRM4 (0.48) | MEN1TTRALBKMT2AGRM4 | |
| Bifenox SCHEMBL7577487 | 0.77 | TDP1 (0.58) | MEN1TTRALBTHRBKMT2A | |
| Glufosinate SCHEMBL28241259 | 0.76 | GRM4 (0.47) | MEN1TTRALBKMT2AGRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | MEN1 4274/4885TTR 1945/4885ALB 1466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.